Comments to FDA: Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology Share page: Docket Number: FDA-2010-D-0530 CHPA applauds the approach for creating a public forum to collect current research and comments to advance the science of engineered nanomaterials. Download Document Issues: OTC Medicines Sunscreen Other Issues Quality Related Posts Polibrief Per-and Polyfluoroalkyl Substances (PFAS) Nov 20, 2024 Polibrief Over-the-Counter Drug Cosmetic Products Nov 20, 2024 Polibrief OTC Contraceptives Nov 20, 2024